HCP
INSM icon

Hexagon Capital Partners’s Insmed INSM Stock Holding History

Hexagon Capital Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-408
Closed -$31.1K – 866
2025
Q1 		$31.1K Hold
408
– – 0.01% 605
2024
Q4 		$28.2K Sell
408
-23
-5% -$1.66K 0.01% 668
2024
Q3 		$31.5K Hold
431
– – 0.01% 557
2024
Q2 		$28.9K Sell
431
-149
-26% -$5.78K 0.01% 564
2024
Q1 		$15.7K Hold
580
– – ﹤0.01% 742
2023
Q4 		$18K Buy
580
+333
+135% +$8.63K ﹤0.01% 675
2023
Q3 		$6.24K Hold
247
– – ﹤0.01% 862
2023
Q2 		$5.21K Buy
+247
New +$4.69K ﹤0.01% 892
2023
Q1 		– Sell
-40
Closed -$799 – 1475
2022
Q4 		$799 Buy
+40
New +$773 ﹤0.01% 1237

Other funds holding INSM

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Hexagon Capital Partners's INSM Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Insmed (INSM) in Q2 2025, closing a stake of 408 shares — an estimated $31.1K sold.

Hexagon Capital Partners first reported a position in INSM in Q4 2022 and held it in 9 quarters. The position peaked at $31.5K in Q3 2024. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 408 Insmed shares in Q2 2025, an estimated $31.1K.
  • Hexagon Capital Partners first reported a position in Insmed in Q4 2022 and held it in 9 quarters.
  • Hexagon Capital Partners's Insmed position peaked at $31.5K in Q3 2024.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.